MODERATE TO SEVERE NAIL PSORIASIS

Clinical trials for MODERATE TO SEVERE NAIL PSORIASIS explained in plain language.

Never miss a new study

Get alerted when new MODERATE TO SEVERE NAIL PSORIASIS trials appear

Sign up with your email to follow new studies for MODERATE TO SEVERE NAIL PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for nail psoriasis: drug shows promise in phase 3 trial

Disease control Completed

This study tested a drug called tildrakizumab in 99 adults with moderate to severe nail psoriasis, a condition causing nail damage and pain. Participants received either the drug or a placebo for 28 weeks to see if it improved nail appearance and symptoms. The goal was to find a …

Matched conditions: MODERATE TO SEVERE NAIL PSORIASIS

Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control

Last updated May 07, 2026 18:39 UTC

MODERATE TO SEVERE NAIL PSORIASIS

Get alerted when new MODERATE TO SEVERE NAIL PSORIASIS trials appear

New hope for nail psoriasis: drug shows promise in phase 3 trial